durapatite has been researched along with Osteolysis in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (20.31) | 18.2507 |
2000's | 26 (40.63) | 29.6817 |
2010's | 23 (35.94) | 24.3611 |
2020's | 2 (3.13) | 2.80 |
Authors | Studies |
---|---|
Laude, F; Ramos-Pascual, S; Saffarini, M; Sales, J; Viamont-Guerra, MR | 1 |
Ding, X; Feng, W; Kc, A; Liang, J; Liao, S; Lin, X; Liu, Q; Liu, Y; Song, F; Song, H; Su, Y; Wang, Z; Xu, J; Zhao, J | 1 |
Bachy, M; Corté, L; Hannouche, D; Ku, DN; Moreau, D; Petite, H; Proudhon, H; Villain, A | 1 |
Huang, Y; Qin, A; Song, F; Tickner, J; Wei, C; Xu, J; Yang, M; Zhao, J; Zhou, L | 1 |
Cunningham, CC; Dunne, A; Hobbs, C; Kelly, DJ; Mahon, OR; McCarthy, GM; Nicolosi, V; O'Hanlon, S | 1 |
Feng, W; Huang, H; Li, F; Li, G; Li, J; Liao, S; Liu, Y; Ma, S; Wei, Q; Wei, Y; Yao, J; Zhong, C | 1 |
Cai, X; Chen, H; Cheng, Y; He, X; Huang, Q; Li, Y; Lin, K; Wang, Y; Xiao, J; Zhang, Q; Zou, Y | 1 |
Liang, T; Lu, Q; Nong, X; Wei, C; Wei, G; Zhao, J | 1 |
Feng, WY; Liao, SJ; Lin, XX; Liu, Q; Liu, Y; Ma, ST; Moro, A; Song, FM; Wang, ZY; Xu, J; Zhan, XL; Zhao, JM | 1 |
Duda, GN; Jung, T; Ryd, L; Schell, H; Schmidt-Bleek, K; Zimpfer, E | 1 |
Oonishi, H | 1 |
Choukroun, J; Ghanaati, S; Landes, C; Lorenz, J; Obreja, K; Sader, RA | 1 |
Escandon-Rodriguez, A; Hernández-Vaquero, D; Pérez-Coto, I; Sandoval-García, MÁ; Suárez-Vázquez, A | 1 |
Boldt, JG; Cartillier, JC; Machenaud, A; Vidalain, JP | 1 |
Ishidou, Y; Komiya, S; Nagano, S; Nakashima, T; Sasaki, H; Setoguchi, T; Shimada, H; Yokouchi, M | 1 |
Cordero-Ampuero, J; García-Cimbrelo, E; García-Rey, E | 1 |
Rahbek, O; Stilling, M; Søballe, K | 1 |
Alanen, K; Kohonen, I; Koivu, H; Sipola, E; Tiusanen, H; Vahlberg, T | 1 |
Anderson, J; Baker, PN; Chuter, G; McMurtry, IA; Port, A | 1 |
Behari, J; Prakash, D | 1 |
Beaufils, P; Beldame, J; Carreras, F; Oger, P | 1 |
Asencio, G; Bidar, R; Kouyoumdjian, P; Munini, E | 1 |
Caballero, MJ; Canales, V; Herrera, A; Mateo, JJ; Panisello, JJ; Sola, A | 1 |
Cossetto, DJ; Gouda, AD | 1 |
Banco, RJ; Jenis, LG | 1 |
Allain, J; Goutallier, D; Le Mouel, S | 1 |
Bliss, JM; Colwell, CW; Law, PL; Patil, SS | 1 |
Belt, EA; Ikävalko, M; Kautiainen, H; Kokkonen, A; Tiihonen, R | 1 |
Maruyama, M; Tensho, K; Terayama, K; Wakabayashi, S | 1 |
Ashino, H; Dozono, H; Hino, A; Kasahara, H; Minamizawa, T; Oshikiri, S; Satake, M; Suwada, J; Suzuki, K | 1 |
Cao, X; Niu, S; Zhang, Y; Zhu, J; Zhu, Q | 1 |
Capello, WN; D'Antonio, JA; Feinberg, JR; Manley, MT | 3 |
Heyligers, IC; van Haaren, EH | 1 |
Cabanela, ME; Harmsen, WS; Harrington, J; Lewallen, DG; Sanchez-Sotelo, J | 1 |
Fukase, M; Hotta, T; Ishikawa, S; Kawashima, H; Ogose, A | 1 |
Blacha, J | 1 |
Blackburn, J; Blunn, GW; Coathup, MJ; Cunningham, JL; Goodship, AE; Smith, T | 1 |
Capello, WN; D'Antonio, JA; Feinberg, JR; Geesink, RG; Jaffe, WL; Manley, MT | 1 |
Passuti, N; Terver, S | 1 |
Bierbaum, BE; Bono, JV; Kelly, SJ; Robbins, CE; Ward, DM | 1 |
Blanco-Pozo, A; Garcia-Cimbrelo, E; Garcia-Rey, E; Martí, E; Murcia-Mazón, A | 1 |
Kim, SC; Ohashi, H; Oonishi, H | 1 |
Blunn, G; Goodship, A; Hua, J; Korda, M | 1 |
Ha, YC; Kim, HJ; Kim, SY; Kim, TY; Koo, KH | 1 |
Bloebaum, RD; Dupont, JA | 1 |
Bauer, TW | 2 |
Binnington, A; Fornasier, V; Kraemer, WJ; Maistrelli, GL; Zhao, JF | 1 |
Breuer, E; Golomb, G; Klenner, T; Krempien, B; Mönkkönen, J; Ornoy, A; Patlas, N; Schlossman, A; Similä, J; Stadler, H; Van Gelder, JM | 1 |
Aebi, U; Hefti, A; Morscher, EW | 1 |
Hyde, ID; Loupasis, G; Morris, EW | 1 |
Furlong, R | 2 |
Frech, W; Herberts, P; Kärrholm, J; Malchau, H; Nivbrant, B; Snorrason, F | 1 |
Thanner, J | 1 |
Bookman, I; Davey, JR; Kreder, HK; Yee, AJ | 1 |
Overgaard, S; Søballe, K | 1 |
Bendix, K; Jensen, TB; Overgaard, S; Rahbek, O; Søballe, K | 1 |
Oosterbos, CJ; Rahmy, AI; Tonino, AJ | 1 |
Iwaki, H; Kadoya, Y; Kin, N; Oonishi, H | 1 |
Hernández Cortés, P; Hernández Hernández, MA; Mesa Ramos, F; Nájera Sagastume, OO; Pajares López, M | 1 |
Donath, K; Schulte, W | 1 |
6 trial(s) available for durapatite and Osteolysis
Article | Year |
---|---|
Nanocrystalline hydroxyapatite-based material already contributes to implant stability after 3 months: a clinical and radiologic 3-year follow-up investigation.
Topics: Adult; Aged; Bone Substitutes; Dental Implants; Dental Plaque; Dental Prosthesis Retention; Dental Restoration Failure; Durapatite; Female; Follow-Up Studies; Gingival Recession; Humans; Male; Maxilla; Middle Aged; Nanoparticles; Osseointegration; Osteolysis; Periodontal Index; Radiography; Sinus Floor Augmentation; Survival Analysis; Time Factors | 2014 |
Inferior survival of hydroxyapatite versus titanium-coated cups at 15 years.
Topics: Aged; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Equipment Safety; Female; Follow-Up Studies; Hip Prosthesis; Humans; Joint Instability; Kaplan-Meier Estimate; Male; Materials Testing; Middle Aged; Osteoarthritis, Hip; Osteolysis; Probability; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Statistics, Nonparametric; Time Factors; Titanium; Treatment Outcome | 2009 |
Arc-deposited hydroxyapatite-coated cups: results at four to seven years.
Topics: Adult; Aged; Aluminum Oxide; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Polyethylene; Postoperative Complications; Prospective Studies; Prosthesis Design; Prosthesis Failure; Treatment Outcome | 2005 |
Alumina-on-alumina in THA: a multicenter prospective study.
Topics: Acetabulum; Adult; Aged; Aluminum Oxide; Arthroplasty, Replacement, Hip; Durapatite; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteolysis; Prospective Studies; Prosthesis Failure; Radiography; Reoperation; Treatment Outcome | 2008 |
Hydroxyapatite in total hip arthroplasty. Clinical results and critical issues.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Equipment Failure Analysis; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Osteolysis; Prosthesis Design; Prosthesis Failure; Reoperation | 1998 |
A randomized trial of hydroxyapatite coated prostheses in total hip arthroplasty.
Topics: Acetabulum; Age Factors; Aged; Alloys; Arthroplasty, Replacement, Hip; Biocompatible Materials; Coated Materials, Biocompatible; Durapatite; Female; Femur; Follow-Up Studies; Foreign-Body Migration; Hip Prosthesis; Humans; Hyperostosis; Linear Models; Male; Middle Aged; Osteolysis; Porosity; Prospective Studies; Prosthesis Design; Radiography; Sex Factors; Surface Properties; Titanium | 1999 |
58 other study(ies) available for durapatite and Osteolysis
Article | Year |
---|---|
Effect of femoral stem surface coating on clinical and radiographic outcomes of cementless primary total hip arthroplasty: a patient-matched retrospective study.
Topics: Arthroplasty, Replacement, Hip; Durapatite; Follow-Up Studies; Hip Prosthesis; Humans; Hypertrophy; Osteolysis; Prosthesis Design; Reoperation; Retrospective Studies; Treatment Outcome | 2023 |
Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-κB and MAPK pathways.
Topics: Animals; Arthroplasty, Replacement; Bone Resorption; Cell Line; Durapatite; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Developmental; Genistein; Humans; Inflammation; Interleukin-1alpha; Interleukin-1beta; Mice; NF-kappa B; Osteoclasts; Osteogenesis; Osteolysis; Osteoporosis; Prostheses and Implants; Signal Transduction; Titanium; Tumor Necrosis Factor-alpha | 2021 |
In vivo evaluation of the bone integration of coated poly(vinyl-alcohol) hydrogel fiber implants.
Topics: Animals; Biocompatible Materials; Bone and Bones; Durapatite; Extracellular Matrix; Hydrogels; Hydrolysis; Ligaments; Male; Materials Testing; Osseointegration; Osteolysis; Polyethylene Terephthalates; Polyvinyl Alcohol; Prostheses and Implants; Rabbits; X-Ray Microtomography | 2017 |
Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
Topics: Animals; Anti-Inflammatory Agents; Calcium Signaling; Disease Models, Animal; Dose-Response Relationship, Drug; Durapatite; Glucosides; Lipopolysaccharides; Luteolin; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; RAW 264.7 Cells; Skull; Time Factors | 2018 |
Orthopaedic implant materials drive M1 macrophage polarization in a spleen tyrosine kinase- and mitogen-activated protein kinase-dependent manner.
Topics: Animals; Biocompatible Materials; Cell Polarity; Durapatite; Humans; Joint Prosthesis; Macrophages; Mitogen-Activated Protein Kinases; Osteoarthritis; Osteolysis; Polymethyl Methacrylate; Prosthesis Failure; Protein-Tyrosine Kinases; Real-Time Polymerase Chain Reaction; Spleen | 2018 |
Gö6983 attenuates titanium particle-induced osteolysis and RANKL mediated osteoclastogenesis through the suppression of NFκB/JNK/p38 pathways.
Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Down-Regulation; Durapatite; Humans; In Vitro Techniques; Indoles; Male; Maleimides; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoblasts; Osteoclasts; Osteogenesis; Osteolysis; p38 Mitogen-Activated Protein Kinases; Prosthesis Failure; Protein Kinase Inhibitors; RANK Ligand; Skull; Titanium | 2018 |
Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Cells, Cultured; Combined Modality Therapy; Durapatite; Heterografts; Hyperthermia, Induced; Indoles; Infrared Rays; Irinotecan; Melanins; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteolysis; Phototherapy; Polymers; Tissue Distribution | 2018 |
Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
Topics: Animals; Arthroplasty, Replacement; Bone Resorption; Cell Proliferation; Disease Models, Animal; Durapatite; Furans; Gene Expression Regulation, Developmental; Humans; Lignans; Mice; Osteoclasts; Osteogenesis; Osteolysis; Prostheses and Implants; RANK Ligand; Titanium; Transcription Factor RelA | 2019 |
Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
Topics: Animals; Biomarkers; Bone Resorption; Cell Differentiation; Disease Models, Animal; Durapatite; Flavonoids; Gene Expression Regulation; Glycosides; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteolysis; Proto-Oncogene Proteins c-fos; RANK Ligand; RAW 264.7 Cells; Skull; Titanium | 2019 |
Treatment of osteochondral defects: chondrointegration of metal implants improves after hydroxyapatite coating.
Topics: Animals; Bone-Implant Interface; Cartilage, Articular; Coated Materials, Biocompatible; Durapatite; Female; Hyaline Cartilage; Metals; Osteolysis; Prostheses and Implants; Prosthesis Design; Prosthesis Failure; Random Allocation; Sheep | 2019 |
A long term histological analysis of effect of interposed hydroxyapatite between bone and bone cement in THA and TKA.
Topics: Acetabulum; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biocompatible Materials; Durapatite; Female; Femur; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Osseointegration; Osteolysis | 2012 |
Influence of clinical and radiological variables on the extent and distribution of periprosthetic osteolysis in total hip arthroplasty with a hydroxyapatite-coated multiple-hole acetabular component: a magnetic resonance imaging study.
Topics: Acetabulum; Adult; Aged; Arthroplasty, Replacement, Hip; Bone Screws; Coated Materials, Biocompatible; Durapatite; Female; Hip Prosthesis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteolysis; Prosthesis Design; Prosthesis Failure; Radiography | 2014 |
Long-term Bone Remodeling in HA-coated Stems: A Radiographic Review of 208 Total Hip Arthroplasties (THAs) with 15 to 20 Years Follow-up.
Topics: Arthroplasty, Replacement, Hip; Bone Remodeling; Coated Materials, Biocompatible; Durapatite; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Osteolysis; Prospective Studies; Prosthesis Failure; Radiography; Treatment Outcome | 2015 |
Intraosseous epidermoid cyst of the distal phalanx reconstructed with synthetic bone graft.
Topics: Adult; Bone Substitutes; Durapatite; Epidermal Cyst; Female; Finger Phalanges; Humans; Magnetic Resonance Imaging; Male; Osteolysis; Young Adult | 2017 |
Outcome of a hemispherical porous-coated acetabular component with a proximally hydroxyapatite-coated anatomical femoral component: a 12- to 15-year follow-up study.
Topics: Acetabulum; Adult; Aged; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Female; Femur Head; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Joint Dislocations; Male; Middle Aged; Osteolysis; Porosity; Prosthesis Design; Radiography; Treatment Outcome; Young Adult | 2009 |
Severe periprosthetic osteolytic lesions after the Ankle Evolutive System total ankle replacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ankle Joint; Arthroplasty, Replacement; Durapatite; Female; Humans; Image Interpretation, Computer-Assisted; Joint Prosthesis; Male; Middle Aged; Osteolysis; Radiography; Titanium; Young Adult | 2009 |
THA with the ABG I prosthesis at 15 years. Excellent survival with minimal osteolysis.
Topics: Adult; Aged; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Equipment Failure; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Postoperative Complications; Prosthesis Design; Prosthesis Failure; Radiography; Reoperation; Survival Analysis | 2010 |
Synergistic role of hydroxyapatite nanoparticles and pulsed electromagnetic field therapy to prevent bone loss in rats following exposure to simulated microgravity.
Topics: Animals; Combined Modality Therapy; Durapatite; Electromagnetic Fields; Female; Hindlimb Suspension; Magnetic Field Therapy; Nanomedicine; Nanoparticles; Osteogenesis; Osteolysis; Rats; Rats, Wistar; Treatment Outcome; Weightlessness Simulation | 2009 |
Cementless cups do not increase osteolysis risk in metal-on-metal total hip arthroplasty. Apropos of 106 cases.
Topics: Acetabulum; Adult; Aged; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Equipment Failure Analysis; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Metals; Middle Aged; Osseointegration; Osteolysis; Postoperative Complications; Prosthesis Design; Radiography; Reoperation; Risk | 2009 |
Long-term results of the ABG-1 hydroxyapatite coated total hip arthroplasty: analysis of 111 cases with a minimum follow-up of 10 years.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Cohort Studies; Durapatite; Equipment Failure Analysis; Female; Follow-Up Studies; Hip Prosthesis; Humans; Kaplan-Meier Estimate; Male; Materials Testing; Middle Aged; Osteolysis; Probability; Prosthesis Design; Prosthesis Failure; Radiography; Reoperation; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome | 2009 |
Extensive osteolysis caused by polyethylene particle migration in an anatomical hydroxyapatite-coated hip prosthesis: 10 years' follow-up.
Topics: Coated Materials, Biocompatible; Durapatite; Female; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Longitudinal Studies; Male; Middle Aged; Osteolysis; Polyethylene; Prevalence; Prosthesis Failure; Radiography; Range of Motion, Articular; Reoperation; Treatment Outcome | 2010 |
Uncemented tibial fixation total knee arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Durapatite; Female; Follow-Up Studies; Humans; Incidence; Internal Fixators; Knee Joint; Knee Prosthesis; Male; Middle Aged; Osteolysis; Prospective Studies; Prosthesis Design; Radiography; Retrospective Studies; Tibia; Treatment Outcome | 2011 |
Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion.
Topics: Aged; Aged, 80 and over; Calcium Phosphates; Ceramics; Durapatite; Female; Follow-Up Studies; Humans; Incidence; Lumbar Vertebrae; Male; Middle Aged; Osteogenesis; Osteolysis; Pain; Prospective Studies; Radiography; Retrospective Studies; Silicates; Spinal Fusion; Treatment Outcome | 2010 |
Comments on: "Long-term results of the ABG-1 hydroxyapatite coated total hip arthroplasty: Analysis of 111 cases with a minimum follow-up of 10 years".
Topics: Acetabulum; Aluminum Compounds; Coated Materials, Biocompatible; Durapatite; Femur Head; Hip Prosthesis; Humans; Osteolysis; Postoperative Complications; Prosthesis Design; Prosthesis Failure; Reoperation; Zirconium | 2010 |
Hydroxyapatite-coated femoral stem/porous-coated acetabulum survivorship at 15 years.
Topics: Acetabulum; Adult; Aged; Arthroplasty, Replacement, Hip; Durapatite; Female; Femur; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Osteolysis; Prevalence; Prosthesis Failure; Radiography | 2011 |
High rate of osteolytic lesions in medium-term followup after the AES total ankle replacement.
Topics: Adult; Aged; Arthritis, Rheumatoid; Arthroplasty, Replacement, Ankle; Coated Materials, Biocompatible; Durapatite; Female; Follow-Up Studies; Humans; Joint Prosthesis; Male; Middle Aged; Osteoarthritis; Osteolysis; Prosthesis Design; Radiography; Reoperation; Retrospective Studies; Titanium; Young Adult | 2011 |
Hydroxyapatite block for reconstruction of severe dysplasia or acetabular bone defects in total hip arthroplasty: operative technique and clinical outcome.
Topics: Acetabulum; Aged; Arthroplasty, Replacement, Hip; Bone Cements; Bone Transplantation; Durapatite; Female; Follow-Up Studies; Hip Dislocation, Congenital; Hip Joint; Hip Prosthesis; Humans; Incidence; Middle Aged; Osteolysis; Polyethylene; Prospective Studies; Radiography; Reoperation; Retrospective Studies; Treatment Outcome | 2012 |
Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Topics: Animals; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Chelating Agents; Diphosphonates; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Osteolysis; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results | 2011 |
The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debris-induced peri-implant high bone turnover.
Topics: Alendronate; Animals; Bone Density; Cytokines; Durapatite; Male; Models, Animal; Orthopedics; Osteolysis; Prostheses and Implants; Rabbits; Synovial Membrane; Tibia | 2013 |
Ten-year results with hydroxyapatite-coated total hip femoral components in patients less than fifty years old. A concise follow-up of a previous report.
Topics: Adolescent; Adult; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Middle Aged; Osteolysis; Prosthesis Design; Prosthesis Failure; Radiography; Reoperation; Treatment Outcome | 2003 |
Implant wear and osteolysis with a hydroxylapatite-coated screw cup.
Topics: Adult; Aged; Arthroplasty, Replacement, Hip; Biocompatible Materials; Bone Cysts; Durapatite; Female; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Polyethylene; Prosthesis Failure; Radiography | 2003 |
Comparison of wear and osteolysis in hip replacement using two different coatings of the femoral stem.
Topics: Adult; Aged; Arthroplasty, Replacement, Hip; Coated Materials, Biocompatible; Durapatite; Female; Femur; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Prospective Studies; Prosthesis Design; Prosthesis Failure; Reoperation; Survival Analysis | 2004 |
Successful surgical treatment of angiosarcoma of the spine: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Bone Screws; Bone Substitutes; Calcium Compounds; Ceramics; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Durapatite; Etoposide; Follow-Up Studies; Hemangiosarcoma; Humans; Hypesthesia; Ifosfamide; Internal Fixators; Male; Middle Aged; Osteolysis; Prostheses and Implants; Prosthesis Implantation; Remission Induction; Silicates; Spinal Cord Compression; Spinal Neoplasms; Thoracic Vertebrae | 2004 |
High osteolysis and revision rate with the hydroxyapatite-coated ABG hip prostheses: 65 hips in 56 young patients followed for 5-9 years.
Topics: Adult; Durapatite; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Postoperative Complications; Prosthesis Design; Prosthesis Failure; Reoperation | 2004 |
Role of hydroxyapatite coating in resisting wear particle migration and osteolysis around acetabular components.
Topics: Animals; Coated Materials, Biocompatible; Durapatite; Equipment Failure Analysis; Foreign-Body Reaction; Hip Prosthesis; Joint Instability; Male; Materials Testing; Osteolysis; Prosthesis Failure; Recovery of Function; Sheep; Treatment Outcome | 2005 |
Hydroxyapatite-coated femoral components: 15-year minimum followup.
Topics: Adolescent; Adult; Aged; Biocompatible Materials; Coated Materials, Biocompatible; Durapatite; Female; Femur; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Prosthesis Failure; Reoperation | 2006 |
[Metal on metal bearing surfaces in total hip arthroplasty: a survey of material incidents].
Topics: Alloys; Arthroplasty, Replacement, Hip; Biocompatible Materials; Cementation; Chromium; Coated Materials, Biocompatible; Cobalt; Durapatite; Follow-Up Studies; France; Hip Dislocation; Hip Prosthesis; Humans; Osseointegration; Osteolysis; Polyethylene; Product Surveillance, Postmarketing; Prospective Studies; Prosthesis Design; Prosthesis Failure; Reoperation | 2007 |
Use of a hydroxyapatite-coated stem in patients with Dorr Type C femoral bone.
Topics: Alloys; Arthroplasty, Replacement, Hip; Durapatite; Female; Femur; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Osseointegration; Osteolysis; Prosthesis Design; Radiography; Range of Motion, Articular; Recovery of Function; Retrospective Studies; Time Factors; Titanium; Treatment Outcome | 2007 |
THA with hydroxyapatite granules at cement-bone interface: 15- to 20-year results.
Topics: Acetabulum; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Bone Cements; Durapatite; Femur; Femur Head Necrosis; Follow-Up Studies; Humans; Middle Aged; Osteoarthritis, Hip; Osteolysis; Postoperative Complications; Prospective Studies; Prosthesis Failure; Retrospective Studies | 2008 |
Use of mesenchymal stem cells to enhance bone formation around revision hip replacements.
Topics: Animals; Arthroplasty, Replacement, Hip; Biocompatible Materials; Bone Transplantation; Durapatite; Femur; Mesenchymal Stem Cell Transplantation; Models, Animal; Osteogenesis; Osteolysis; Sheep; Tissue Engineering; Transplantation, Homologous | 2008 |
THA using an anatomic stem in patients with femoral head osteonecrosis.
Topics: Acetabulum; Arthroplasty, Replacement, Hip; Biocompatible Materials; Durapatite; Female; Femur; Femur Head Necrosis; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Osteolysis; Polyethylene; Prosthesis Design; Prosthesis Failure; Radiography; Reoperation; Retrospective Studies; Stress, Mechanical; Time Factors; Treatment Outcome | 2008 |
Osteolysis from a press-fit hydroxyapatite-coated implant. A case study.
Topics: Acetabulum; Durapatite; Female; Foreign-Body Migration; Hip Prosthesis; Humans; Hydroxyapatites; Microscopy, Electron, Scanning; Middle Aged; Osteoarthritis; Osteolysis; Prosthesis Design; Prosthesis Failure; Reoperation; Titanium | 1993 |
Hydroxyapatite: coating controversies.
Topics: Animals; Bone Remodeling; Bone Resorption; Durapatite; Hip Prosthesis; Humans; Hydrogen-Ion Concentration; Knee Prosthesis; Materials Testing; Osteoclasts; Osteolysis; Postoperative Complications; Prosthesis Design; Prosthesis Failure; Surface Properties | 1995 |
Migration of polyethylene wear debris in hip arthroplasties: a canine model.
Topics: Animals; Biocompatible Materials; Bone Cements; Dogs; Durapatite; Hip Prosthesis; Lymph Nodes; Materials Testing; Osteolysis; Polyethylenes; Prosthesis Failure | 1995 |
In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.
Topics: Animals; Bioprosthesis; Bone Resorption; Calcinosis; Carcinoma 256, Walker; Cell Line; Cell Survival; Diphosphonates; Durapatite; Etidronic Acid; Female; Macrophages; Mice; Osteolysis; Pamidronate; Rats; Rats, Wistar | 1997 |
Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating.
Topics: Acetabulum; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Biocompatible Materials; Calcium; Carbon; Chromium Alloys; Durapatite; Electron Probe Microanalysis; Female; Femur; Femur Head; Follow-Up Studies; Foreign-Body Migration; Hip Prosthesis; Humans; Incidence; Male; Microscopy, Electron, Scanning; Middle Aged; Osteolysis; Oxygen; Phosphorus; Polyethylenes; Prosthesis Design; Prosthesis Failure; Radiography; Reoperation; Surface Properties | 1998 |
The Furlong hydroxyapatite-coated total hip replacement in patients under age 51. A 6-year follow-up study.
Topics: Acetabulum; Adult; Age Factors; Alloys; Arthroplasty, Replacement, Hip; Biocompatible Materials; Chi-Square Distribution; Durable Medical Equipment; Durapatite; Female; Femoral Fractures; Femur; Follow-Up Studies; Hip Dislocation; Hip Prosthesis; Humans; Intraoperative Complications; Joint Instability; Male; Middle Aged; Osseointegration; Osteolysis; Pain; Patient Satisfaction; Polyethylenes; Postoperative Complications; Prosthesis Design; Prosthesis Failure; Radiography; Range of Motion, Articular; Reoperation; Surface Properties; Titanium; Treatment Outcome | 1998 |
Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating.
Topics: Acetabulum; Arthroplasty, Replacement, Hip; Calcium Phosphates; Durapatite; Electron Probe Microanalysis; Follow-Up Studies; Hip Prosthesis; Humans; Osteolysis; Polyethylenes; Prosthesis Design; Spectrophotometry, Infrared; Surface Properties | 1998 |
Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating.
Topics: Acetabulum; Durapatite; Hip Prosthesis; Humans; Osteolysis; Polyethylenes; Prosthesis Design; Surface Properties | 1998 |
Fixation and metal release from the Tifit femoral stem prosthesis. 5-year follow-up of 64 cases.
Topics: Adult; Aged; Alloys; Arthroplasty, Replacement, Hip; Bone Cements; Coated Materials, Biocompatible; Durapatite; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteolysis; Pain, Postoperative; Prosthesis Design; Prosthesis Failure; Radiography; Titanium | 1998 |
The acetabular component in total hip arthroplasty. Evaluation of different fixation principles.
Topics: Absorbable Implants; Acetabulum; Adult; Aged; Arthroplasty, Replacement, Hip; Biocompatible Materials; Biomechanical Phenomena; Bone Cements; Bone Screws; Calcium Phosphates; Case-Control Studies; Ceramics; Data Interpretation, Statistical; Durapatite; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Orthopedic Fixation Devices; Osteolysis; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Spectrophotometry, Atomic; Time Factors; Titanium | 1999 |
Polyethylene wear, osteolysis and acetabular loosening with an HA-coated hip prosthesis.
Topics: Coated Materials, Biocompatible; Durapatite; Equipment Failure Analysis; Hip Prosthesis; Humans; Osteolysis; Polyethylene; Prosthesis Design; Prosthesis Failure | 2000 |
Sealing effect of hydroxyapatite coating: a 12-month study in canines.
Topics: Animals; Awards and Prizes; Biocompatible Materials; Dogs; Durapatite; Knee Prosthesis; Osteolysis; Prosthesis Failure | 2000 |
Proximal femoral bone loss and increased rate of fracture with a proximally hydroxyapatite-coated femoral component.
Topics: Durapatite; Femoral Fractures; Hip Prosthesis; Humans; Osteolysis; Prosthesis Design; Prosthesis Failure | 2001 |
Hydroxyapatite coated hip prosthesis followed up for 5 years.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Biocompatible Materials; Bone Remodeling; Chi-Square Distribution; Coated Materials, Biocompatible; Durapatite; Female; Hip Joint; Hip Prosthesis; Humans; Logistic Models; Male; Middle Aged; Osseointegration; Osteoarthritis, Hip; Osteolysis; Prospective Studies; Prosthesis Failure; Prosthesis-Related Infections; Radiography; Survival Analysis; Treatment Outcome | 2001 |
Total hip arthroplasty with a modified cementing technique using hydroxyapatite granules.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Bone Cements; Durapatite; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteolysis; Prosthesis Design; Prosthesis Failure; Radiography; Reoperation; Surgical Instruments | 2001 |
Hydroxyapatite-coated stems with metaphyseal and diaphyseal press-fit. Eleven-year follow-up results.
Topics: Aged; Alloys; Arthroplasty, Replacement, Hip; Biocompatible Materials; Biomechanical Phenomena; Durapatite; Female; Follow-Up Studies; Hip; Humans; Male; Middle Aged; Osteolysis; Pain; Postoperative Complications; Prosthesis Design; Survival Analysis; Titanium | 2002 |
[Side effects and dangers in hydroxylapatite implantation].
Topics: Bone Regeneration; Dental Implantation, Endosseous; Durapatite; Humans; Hydroxyapatites; Male; Osteolysis; Trigeminal Nerve Injuries | 1991 |